Research Topics
| Daniel R GomezSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experienceDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 70:1365-72. 2008..To analyze the recent experience of patients with adenoid cystic carcinoma treated with radiation therapy at Memorial Sloan-Kettering Cancer Center...
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancersDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 73:1096-103. 2009..To present our single-institution experience of intensity-modulated radiotherapy (IMRT) for oral cavity cancer...- Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid glandDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cancer 115:2128-37. 2009..The aim of the current study was to determine patterns of failure and adverse prognostic features... - Radiotherapy after surgical resection for head and neck mucosal melanomaAbraham J Wu
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
Am J Clin Oncol 33:281-5. 2010..To present our single-institution experience with postoperative radiotherapy for mucosal melanoma of the head and neck... - Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancerDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 81:e207-13. 2011..However, the incidence of this complication with intensity-modulated radiation therapy (IMRT) and dental sequelae with this technique have not been fully elucidated... - Unresectable carcinoma of the paranasal sinuses: outcomes and toxicitiesBradford S Hoppe
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Int J Radiat Oncol Biol Phys 72:763-9. 2008..To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy... - Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancerQingsong Pang
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 97, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 85:1332-9. 2013..We investigated potential associations between single nucleotide polymorphisms (SNPs) in HSPB1 and risk of RP after chemoradiation for non-small cell lung cancer (NSCLC)... - Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderlyShervin M Shirvani
Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Int J Radiat Oncol Biol Phys 84:1060-70. 2012.... - Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesotheliomaDaniel R Gomez
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77054, USA
J Thorac Oncol 8:238-45. 2013.... - Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancerJose L Lopez Guerra
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Int J Radiat Oncol Biol Phys 83:e537-43. 2012.... - Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based studyDaniel R Gomez
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
Cancer 119:1428-36. 2013..For this population-based study, the authors assessed the rates of antiemetic prophylaxis use, and predictors of such use, among patients who were receiving platinum-based chemotherapy for lung cancer between 2001 and 2007... 
Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapyDaniel R Gomez
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Radiother Oncol 93:414-8. 2009..There has been an increase in the utilization of single-fraction stereotactic body radiation therapy (SBRT) to treat thoracic structures, but there have been few reports describing toxicity outcomes with this treatment...- A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumorsDaniel R Gomez
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Cancer 118:444-51. 2012..The optimal treatment for locally advanced superior sulcus tumors is not clear. The authors report long-term results of a trial examining the safety and efficacy of surgery followed by concurrent chemoradiation therapy for this disease... - High failure rate in spinal ependymomas with long-term follow-upDaniel R Gomez
Department of Radiation Oncology, University of California, San Francisco, CA 94143, USA
Neuro Oncol 7:254-9. 2005..The overall high rate of recurrence leads us to recommend radiation to doses of 45 to 54 Gy for all patients who do not have gross total resections, and long, close follow-up...